RTHP-08. LONG-TERM FOLLOW UP OF HIGH-RISK LOW-GRADE GLIOMA PATIENTS TREATED WITH RADIOTHERAPY (RT) OR RT AND ADJUVANT TEMOZOLAMIDE OR PROCARBAZINE, CCNU, AND VINCRISTINE (PCV) CHEMOTHERAPY AT A SINGLE INSTITUTION
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.